Takeda positioning itself to assume EU stem cell production within 5 years – FiercePharma
FiercePharma |
Takeda positioning itself to assume EU stem cell production within 5 years
FiercePharma Takeda Pharma is positioning itself to take over stem cell production in Europe from its partner TiGenix by 2021 after Swissmedic—the Swiss Agency for Therapeutic Products—said last week it has accepted for review the file for an investigational drug … |
